Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Glen Reid

Showing results (21-30 of 88) with videos related to

Pageof 9
Sort By:
Journal of Clinical Pathology|July 2, 2013
Challenges and controversies in the diagnosis of mesothelioma: Part 1. Cytology-only diagnosis, biopsies, immunohistochemistry, discrimination between mesothelioma and reactive mesothelial hyperplasia, and biomarkersDouglas W Henderson, Glen Reid, Steven C Kao, et al.
Disease Markers|March 31, 2015
Blockade of aquaporin 1 inhibits proliferation, motility, and metastatic potential of mesothelioma in vitro but not in an in vivo modelSonja Klebe, Kim Griggs, Yuen Cheng, et al.
Journal of Clinical Pathology|July 9, 2013
Challenges and controversies in the diagnosis of malignant mesothelioma: Part 2. Malignant mesothelioma subtypes, pleural synovial sarcoma, molecular and prognostic aspects of mesothelioma, BAP1, aquaporin-1 and microRNADouglas W Henderson, Glen Reid, Steven C Kao, et al.
BMC Research Notes|November 19, 2017
The analysis of novel microRNA mimic sequences in cancer cells reveals lack of specificity in stem-loop RT-qPCR-based microRNA detectionPatrick Winata, Marissa Williams, Eileen McGowan, et al.
Journal of Clinical Medicine|June 20, 2018
An Update on Predictive Biomarkers for Treatment Selection in Non-Small Cell Lung CancerTamkin Ahmadzada, Steven Kao, Glen Reid, et al.
Lung Cancer (Amsterdam, Netherlands)|July 14, 2024
Asbestos-Related lung Cancer: An underappreciated oncological issueNico van Zandwijk, Arthur L Frank, Glen Reid, et al.
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
Tumour suppressor microRNAs contribute to drug resistance in malignant pleural mesothelioma by targeting anti-apoptotic pathwaysMarissa Williams, Yuen Yee Cheng, Monica Phimmachanh, et al.
Critical Reviews in Oncology/Hematology|April 25, 2020
Extracellular vesicles as biomarkers in malignant pleural mesothelioma: A reviewTamkin Ahmadzada, Steven Kao, Glen Reid, et al.
Pathology|March 26, 2011
Molecular biomarkers in malignant mesothelioma: state of the artSteven Chuan-Hao Kao, Glen Reid, Nico van Zandwijk, et al.
Journal of the American Society of Nephrology : JASN|July 23, 2003
Protein kinase C activation downregulates human organic anion transporter 1-mediated transport through carrier internalizationNatascha A Wolff, Karen Thies, Nicola Kuhnke, et al.
Pageof 9

Showing results (21-30 of 88) with videos related to

Sort By:
Pageof 9
Journal of Clinical Pathology|July 2, 2013
Challenges and controversies in the diagnosis of mesothelioma: Part 1. Cytology-only diagnosis, biopsies, immunohistochemistry, discrimination between mesothelioma and reactive mesothelial hyperplasia, and biomarkersDouglas W Henderson, Glen Reid, Steven C Kao, et al.
Disease Markers|March 31, 2015
Blockade of aquaporin 1 inhibits proliferation, motility, and metastatic potential of mesothelioma in vitro but not in an in vivo modelSonja Klebe, Kim Griggs, Yuen Cheng, et al.
Journal of Clinical Pathology|July 9, 2013
Challenges and controversies in the diagnosis of malignant mesothelioma: Part 2. Malignant mesothelioma subtypes, pleural synovial sarcoma, molecular and prognostic aspects of mesothelioma, BAP1, aquaporin-1 and microRNADouglas W Henderson, Glen Reid, Steven C Kao, et al.
BMC Research Notes|November 19, 2017
The analysis of novel microRNA mimic sequences in cancer cells reveals lack of specificity in stem-loop RT-qPCR-based microRNA detectionPatrick Winata, Marissa Williams, Eileen McGowan, et al.
Journal of Clinical Medicine|June 20, 2018
An Update on Predictive Biomarkers for Treatment Selection in Non-Small Cell Lung CancerTamkin Ahmadzada, Steven Kao, Glen Reid, et al.
Lung Cancer (Amsterdam, Netherlands)|July 14, 2024
Asbestos-Related lung Cancer: An underappreciated oncological issueNico van Zandwijk, Arthur L Frank, Glen Reid, et al.
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
Tumour suppressor microRNAs contribute to drug resistance in malignant pleural mesothelioma by targeting anti-apoptotic pathwaysMarissa Williams, Yuen Yee Cheng, Monica Phimmachanh, et al.
Critical Reviews in Oncology/Hematology|April 25, 2020
Extracellular vesicles as biomarkers in malignant pleural mesothelioma: A reviewTamkin Ahmadzada, Steven Kao, Glen Reid, et al.
Pathology|March 26, 2011
Molecular biomarkers in malignant mesothelioma: state of the artSteven Chuan-Hao Kao, Glen Reid, Nico van Zandwijk, et al.
Journal of the American Society of Nephrology : JASN|July 23, 2003
Protein kinase C activation downregulates human organic anion transporter 1-mediated transport through carrier internalizationNatascha A Wolff, Karen Thies, Nicola Kuhnke, et al.
Pageof 9